One aspect concerns inhibition by hydrolysates of angiotensin I-converting enzyme (ACE), involved in regulation of hypertension, acting as a catalyst for converting Angiotensin-I to Angiotensin-II, a potent vasoconstrictor peptide modulating blood pressure [55]. The gene discussed is ACE; the disease is hypertensive disorder.